Medication Reconciliation and Blood Glucose Monitoring Failure
Summary
The facility failed to accurately reconcile medications on admission and failed to monitor blood glucose levels for one resident with dementia, diabetes with long-term insulin use, and chronic kidney disease. The resident was admitted with severe cognitive impairment, and the record showed a diagnosis of diabetes with long-term use of insulin entered into the EMR shortly after admission. Referral documents received before admission included a physician progress note stating the resident remained on Lantus 12 units daily and a medication list showing Lantus Solostar U-100 Insulin 12 units daily with no end date. The facility’s records showed no insulin, oral hypoglycemic medication, or point-of-care blood glucose testing ordered or provided from admission until after the resident returned from hospitalization. The October MAR/TAR and order summary report did not show diabetic medications or glucose monitoring during that period. Laboratory testing obtained after admission showed a random glucose of 348 and an A1C of 11.6. The resident later presented to the ED with hyperglycemia, and the hospital documentation stated the resident had not been receiving insulin for the prior 2 weeks after moving from the previous facility because the medication was not listed on the medication list received by the current facility. Facility interviews and record review showed the admission referral documents contained conflicting medication information, including one set that listed insulin and another medication profile that did not. The DON stated there was no designated staff person responsible for reviewing referral documents and that the responsibility fell among the entire IDT. The DON also confirmed the facility should have sought clarification from the previous physician and current provider because of the differences in the medication lists. The facility’s diabetic protocol stated residents with diabetes or on medications that could lower blood sugar should have glucose monitoring and treatment orders unless otherwise ordered, and that bedside blood glucose testing should be administered for residents with symptoms such as malaise or confusion.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.